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Introduction
Developmental language disorder (DLD), a condition in which 
there are unexplained and persistent difficulties with language 
acquisition, affects around 7% of children (Norbury et al., 
2016). Family studies show that DLD runs in families (Bishop, 
2008), yet it has proved hard to identify any genetic or environ-
mental factors that substantially increase risk. One reason is 
that DLD appears to be a complex multifactorial disorder where 
influences of individual genetic variants (alleles) are typically 
of small effect, and may interact with other genetic factors and 
with the environment. Indeed, the ways in which disorders pat-
tern in families suggest that common genetic variants that confer 
risk of language disorder may lead to an autistic phenotype when 
they occur with other genetic risk factors (Bishop, 2010). Thus 
the specific phenotype can depend on the constellation of 
genetic variants, rather than there being separate risk factors for 
DLD and autism spectrum disorder (ASD).
Rather than recruiting increasingly large numbers to try to 
find reliable associations between language disorders and genetic 
variants in genome-wide studies, one way forward is to study 
rare disorders that have a large impact on the phenotype, which 
may point to functional pathways involved in more common 
forms of disorder. One instance of a striking association between 
a genetic condition and language disorder in children of nor-
mal intelligence is provided by the sex chromosome trisomies 
(SCTs), each of which affects 1–1.5 per 1000 children (Nielsen 
& Wohlert, 1991). In the 1960s, research was initiated to investi-
gate neurodevelopmental outcomes of children with SCT detected 
on neonatal screening. A systematic review of these studies 
showed that in all three trisomies there were high rates of speech 
and language impairment, motor problems, and educational dif-
ficulties, despite IQ being within normal limits in most cases 
(Leggett et al., 2010). Furthermore, studies of samples who 
have developmental language disorder of unknown cause find 
an increased prevalence of sex chromosome trisomies (Simpson 
et al., 2014).
In a study of children with sex chromosome trisomies 
identified on prenatal screening, Bishop et al. (2011) found that 
7 of 30 (24%) girls with karyotype 47,XXX, 9 of 19 (47%) boys 
with 47, XXY and 15 of 21 (71%) boys with 47,XYY had a his-
tory of speech and language-therapy, compared with rates of 4% 
in sisters and 18% in brothers. Furthermore, this same study 
found that 2 of 19 (11%) boys with 47, XXY, and 4 of 21 (20%) 
boys with 47,XYY had received a diagnosis of ASD, com-
pared with an estimated national prevalence rate of 0.2% in girls 
and 0.6% in boys. In addition, many children with SCTs who 
were not diagnosed with ASD had evidence of communication 
difficulties on parental report, including pragmatic (autistic-like) 
problems, in all three karyotypes. More recent research has 
provided further evidence of a link with autism as well as 
other neurodevelopmental disorders in boys with a sex chromo-
some trisomy (Ross et al., 2012).
The impact of a chromosome trisomy is influenced by distinc-
tive characteristics of the sex chromosomes. In most cases, the 
phenotypic effects of SCTs are much less severe than the impact 
of an autosomal trisomy: Down syndrome (trisomy 21) usually 
leads to intellectual disability, and most other trisomies are 
lethal. Viable trisomies usually involve small chromosomes 
with a low gene count (for example the Y chromosome), presum-
ably reflecting the severe effects associated with altered gene 
dosage. An exception to this rule is the X chromosome. The 
X chromosome has a relatively high gene count, but the 
impact of a duplication is relatively mild because mechanisms 
of inactivation have evolved, such that in typical females, only 
one copy is active, and in effect, both males and females have 
one set of functional genes from this chromosome. In triso-
mies that involve the X chromosome, two copies are inactivated, 
largely negating the presence of additional genetic material. 
There are, however, exceptions to this rule, with between 
12–20% genes escaping inactivation to some extent: These include 
genes in the pseudo-autosomal region, and other genes that 
have homologues on the Y chromosome (Carrel & Brown, 2017).
The fact that there is an increase in problems affecting 
speech, language and communication in all three sex chromosome 
trisomies suggests there is an adverse impact of an additional copy 
of a gene that is expressed and has homologous forms on the X 
and Y chromosomes. Neuroligin-4 (NLGN4) is a strong candi-
date for such a gene, for several reasons (Bishop et al., 2011). 
First, NLGN4X, located on Xp22, escapes inactivation (Berletch 
et al., 2011). Second there is a homologous gene, NLGN4Y on 
the Y chromosome at Yq11.2. Third, neuroligins are expressed in 
brain, as well as other tested tissues (Abrahams & Geschwind, 
2010; Jamain et al., 2003). Fourth, as reviewed by Cao & Tabuchi 
(2017), mutations of NLGN4 have been linked to ASD (Jamain 
et al., 2003; Laumonnier et al., 2004; Lawson-Yuen et al., 2008; 
Marshall et al., 2008; Pampanos et al., 2009; Talebizadeh et al., 
2006; Yan et al., 2008) – although this finding is inconsistent 
and other studies have not found autism in those with mutations 
of NLGN4 (Chocholska et al., 2006; Macarov et al., 2007), or 
have failed to find abnormalities of NLGN4 in those with autism 
(Blasi et al., 2006; Gauthier et al., 2005; Liu et al., 2013; Vincent 
et al., 2004; Yanagi et al., 2012). Fifth, neuroligins are postsynap-
tic transmembrane proteins which mediate development of func-
tional synapses between neurons and are in the same functional 
network as neurexins (Craig & Kang, 2007), which have also 
been implicated in both DLD and ASD (Vernes et al., 2008). 
Jamain et al. (2003) proposed that a defect in NLGN4 may 
abolish formation or function of synapses involved in com-
munication. Note that these authors also implicated another 
X-chromosome neuroligin, NLGN3, in autism, but this is located 
at Xq13, where one copy would be inactivated, and there is 
no homologue on the Y-chromosome. Therefore, unlike 
NLGN4, NLGN3 would not be over-expressed in those with an 
extra X or Y chromosome.
For the reasons described above, we may hypothesise that 
an extra copy of NLGN4 could be implicated in neurodevel-
opmental problems. However, we also need to explain within- 
karyotype variation. Although there is a substantial increase in rates 
of speech, language and social communication problems in chil-
dren with SCTs, the additional chromosome does not cause lan-
guage impairment or ASD in a deterministic fashion. A minority 
of children have no evidence of developmental difficulties, 
a minority are severely affected with disabilities extending across 
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many domains, and most have mild to moderate impairments 
(Linden & Bender, 2002).
The wide variation in outcomes suggests that the extra gene 
dosage could act as a multiplier of other risk factors, which inter-
act with the sex chromosome genes in a dosage-dependent man-
ner and so only assume importance in the subset of individuals 
who have other genetic or environmental risk factors (Bishop & 
Scerif, 2011). This explanation is consistent with rodent research 
comparing the effect of a NLGN3 mutation between differ-
ent strains of mouse, suggesting the impact is dependent on the 
genetic background (Jaramillo et al., 2017). It also is compatible 
with evidence from studies of mutations in NLGN4 in humans, 
where it is noted that the same mutation may be associated with 
different phenotypes within one family (Jamain et al., 2003; 
Laumonnier et al., 2004; Lawson-Yuen et al., 2008; Yan et al., 
2005). As well as autism, NLGN4 associations have been 
described with intellectual disability, language disorder and 
Tourette syndrome (Lawson-Yuen et al., 2008; Yan et al., 2005).
Hypothesis
Our pre-planned analysis is designed to test the ‘double hit’ 
hypothesis
The ‘double hit’ hypothesis: Neuroligins act as a multiplier 
of effects of neurexins
Bishop & Scerif (2011) proposed that the effect of altered 
neuroligin gene dosage depends on the genetic background 
provided by autosomes. In this regard, it is of particular interest 
to note that neuroligin proteins form part of the same functional 
network as a group of presynaptic transmembrane proteins, 
known as neurexins; their interactions play a key role in synap-
togenesis (Hussain & Sheng, 2005). CNTNAP2 encodes a mem-
ber of the neurexin superfamily whose polymorphisms have been 
associated with common forms of language impairment, but 
the effect size is relatively small (Vernes et al., 2008). While 
early functional studies of the CNTNAP2 protein indicated that 
it localises to nodes of Ranvier in axonal membranes, it is now rec-
ognised to have key functions at the synapse (Zweier et al., 2009). 
This raises the possibility that a CNTNAP2 gene variant that has 
a modest effect in individuals of normal karyotype might have 
a much larger impact in the context of overexpression of a neuro-
ligin. This hypothesis predicts that presence of an additional sex 
chromosome will amplify the impact of common genetic vari-
ants that have two characteristics: (a) they have been associated 
with DLD or ASD, and (b) they are in the same functional net-
work as neuroligins. Figure 1 shows two genes of interest to our 
Figure 1. Neurexins (such as NRXN1), neuroligins (such as NLGN4) and contactin-associated proteins (such as CNTNAP2) all form 
part of the synaptic scaffolding system.
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current study, CNTNAPs and Neurexins, interacting with 
neuroligins in the synaptic cleft.
Methods
We report how we determined our sample size, all data 
exclusions, all manipulations, and all measures in the study 
(Simmons et al., 2012).
Power analysis and impact of ascertainment bias
We aimed to recruit sufficient children with trisomies 
to detect an effect size of d = 0.5 for each copy of a given genetic 
variant on a phenotype, equivalent to a standardized regres-
sion slope of 0.25. The anticipated effect size is hard to judge, 
but the average impact of a sex chromosome trisomy on verbal 
IQ is more than one SD from the general population mean 
(Leggett et al., 2010), suggesting that if the trisomy acts as a mul-
tiplier of effects of autosomal variants, this effect could be large. 
When testing variants with a prior association with disorder, 
we can make a directional prediction. We aimed to recruit 150 
children with trisomies, which would have given 94% power to 
detect a slope of 0.25 on one-tailed test. However, we recruited 
only 140 children and had missing data on some variables, 
so numbers, and consequently power, are lower than this. In 
addition, we have to take into account that the sample is not 
representative of children with sex chromosome trisomies, because 
around 50% had the trisomy discovered in childhood when 
developmental difficulties were being investigated (see below). 
We devised a simulation to check the impact of these factors 
on power (see Appendix 5). This showed that a combination 
of N = 130 with 50% postnatally identified (and presumably 
biased) cases with mean phenotype score 0.9 SD below the 
group average (computed from a language factor score), reduced 
power to 87% on one-tailed test.
Participants
Sex chromosome trisomies: After excluding children with 
missing or inadequate DNA, participants included 42 girls with 
trisomy X, 43 boys with Klinefelter syndrome, and 45 boys 
with XYY. These were combined in a single group of 130 chil-
dren for analysis, but are shown broken down by trisomy and back-
ground in Figure 2. Cases were recruited from National Health 
Service Clinical Genetics Centres, from two support groups 
(Unique: the Rare Chromosome Support Group, and the 
Klinefelter Syndrome Association), or from self-referral via 
advertisements on the OSCCI website and our Facebook page. 
A criterion for inclusion was that the child was aware of their 
trisomy status. In a previous study (Bishop et al., 2011) we noted 
that levels of impairment tended to be lower in cases where 
the trisomy was discovered on prenatal screening than in those 
identified later in childhood. We therefore asked parents spe-
cifically about the reason for genetic testing; for 59 children 
aneuoploidy only came to light because of behavioural or 
developmental problems. Note that this means that data from 
this sample should not be used to estimate prevalence of 
neurodevelopmental disorders in sex chromosome trisomies.
Comparison group: Comparison data came from a sample of 
children aged from 6 years 0 months to 11 years 11 months 
who had completed the same test battery, who were taking part 
in a twin study of language and laterality (Wilson & Bishop, 
2018a), and whose first language at home was English. Although 
twinning is a risk factor for early language delay, this effect 
appears to wash out with age, and by school age, genetic fac-
tors play a major role in the aetiology of language disorder 
(Bishop, 2006; Rice et al., 2018). In this sample, we aimed for 
an over-representation of twin pairs in which one or both twins 
had language or literacy problems that might be indicative of 
Figure 2. Flowchart showing characteristics of children recruited to SCT group.
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DLD. This was coded on the basis of parental response on a 
telephone interview: any mention of language delay, history 
of speech and language therapy, current language problems or 
dyslexia was coded as ‘parental concern’. We aimed to recruit 
180 pairs selected on the basis of having language or literacy 
problems (60 MZ, 60 DZ opposite sex and 60 DZ same sex), and 
60 unselected pairs (20 of each type): we fell short of this 
goal as seen in Figure 3. For the current analysis, we grouped 
together all twins, regardless of zygosity and parental concern, 
and then divided into two subsamples by selecting one twin 
from each pair at random, after excluding 18 cases with miss-
ing or insufficient DNA. This means we can replicate the 
analysis for twins with a diploid (typical) karyotype. Note that 
this replication sample is not independent, as the genotype 
for the MZ twins is the same in the two subsamples, and is 
related for DZ twins.
Some children had evidence of autism spectrum disorder 
(N = 15) or intellectual disability (N = 3), and twelve failed a hear-
ing screen on the day of testing, although none of them had any 
known sensorineural hearing loss. For the current study, because 
we were interested in a broader phenotype than pure DLD, 
these cases were retained in the sample.
Test battery
Psychiatric evaluation. In an initial telephone interview, parents 
were asked about the child’s medical and educational history, 
including a question about whether anyone had diagnosed the child 
with a neurodevelopmental disorder such as ASD, developmental 
language disorder (DLD) or specific language impairment, dyslexia 
or dyspraxia. In addition, one or both parents were asked to com-
plete the online Development and Wellbeing Assessment (DAWBA) 
(Goodman et al., 2000) in their own time. 86 parents complied 
with this request. The DAWBA gives information on likelihood 
of the child meeting criteria for a range of psychiatric diag-
noses; a final diagnosis is made by a trained rater who assimilates 
all the information and evaluates it against DSM5 criteria 
(American Psychiatric Association, 2013).
Language, literacy and cognitive assessments. All chil-
dren were seen at home or in a quiet space in their school 
for a neurocognitive assessment, using the battery of lan-
guage and nonverbal ability tests shown in Table 1. Hear-
ing was screened in left and right ears using a DSP Pure Tone 
Audiometer (Micro Audiometric Corporation). The child was 
familiarised with the task of raising their hand on hearing a 
tone using 40 dB (HL) tones. They were then tested with 25 dB 
pure tones at frequencies of 500, 1000, 2000 and 4000 Hz. 
Louder tones were presented in 5 dB steps to establish a thresh-
old at any frequency where a 25 dB tone was not detected. 
Children with an average threshold greater than 30 dB in the bet-
ter ear were categorized as failing the screen. The battery also 
included tests of literacy: the Picture and Digit naming tests 
from the Phonological Assessment Battery (Frederickson et al., 
1997), the Test of Word Reading Efficiency (Torgesen et al., 
1999) and the Neale Analysis of Reading Ability -2 (Neale, 1999), 
Figure 3. Flowchart showing characteristics of children recruited to comparison groups. Information about zygosity, gender and parental 
concern is shown for information, but was not used in the analysis. Because twins are not independent, the final sample was divided into two 
subgroups of 184 and 186 children respectively, each containing one member from each pair, selected at random. (Ns not equal because 
some twins had missing DNA from just one member of the pair).
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but these are not included in the current analysis as there was 
much missing data from the youngest children. In addition, 
handedness and language laterality were assessed. Results 
from laterality assessments were unremarkable and are not 
considered further here (Wilson & Bishop, 2018a; Wilson & 
Bishop, 2018b).
Phenotypes
We will consider three quantitative phenotypes that range 
from a specific measure of a heritable language skill, through 
a more general language measure, to a measure that potentially 
indexes a wide range of neurodevelopmental problems: 
A)    Nonword repetition, which is regarded as a measure 
of phonological short-term memory. This was singled 
out as an individual measure because it has previous-
ly been identified in twin studies as a good marker of 
heritable language problems (Bishop et al., 1996) and 
has also been associated with genetic variants linked to 
language/literacy in the CNTNAP2, CMIP, ATP2C2, 
KIAA0319, and DCDC2 genes (Carrion-Castillo et al., 
2017; Marino et al., 2012; Newbury et al., 2009; 
Newbury et al., 2011; Scerri et al., 2011; Vernes et al., 
2008). In the current study, we used scaled scores from 
Repetition of Nonsense Words from the NEPSY (Korkman 
et al., 1998).
B)    A general language factor derived from the four 
other language tests (Verbal Comprehension, Oromotor 
Sequences, Sentence Repetition and Vocabulary. As docu-
mented in Appendix 2, the decision to combined these 
measures into a single language factor was made after 
exploring the factor structure of the available phenotypic 
measures, with the goal of obtaining a reliable indicator of 
overall language function.
C)    A global measure of burden of neurodevelopmental 
problems extending beyond language, including 
autistic features. This was developed on an ad hoc basis, 
using all available information from parental report 
(see Appendix 3).
DNA collection and analysis
Oragene kits (OG-500, DNA Genotek Inc, Ontario Canada) 
were used to collect saliva for DNA analysis from children with 
SCTs and their parents and available twin pairs. DNA extrac-
tion was performed using an ethanol precipitation protocol as 
detailed in the standard protocol (DNA genotek). All 
extracted DNA was genotyped on the Infinium ‘Global Screening 
Array-24 (v1)’, which includes 692824 SNPs including rare 
and common variations. Data were processed in the Illumina 
BeadStudio/GenomeStudio software (v. 2.03) and all SNPs with 
a GenTrain (quality) score of < 0.5 were excluded at this stage. 
All genotypes were further filtered using PLINK software v1.07 
(Purcell et al., 2007); as recommended by Anderson et al. (2010), 
samples with a genotype success rate below 95% or a heterozy-
gosity rate ±2 SD from the mean were removed, as were SNPs 
with a Hardy-Weinberg equilibrium P < 0.000001 or a minor 
allele frequency of less than 1%. Identity data within families and 
twin-pairs were used to exclude samples with unexpected 
gender or relationships. SNPs that showed an inheritance error 
rate > 1% or skewed missing rates between genotype plates 
were also excluded. Control data (CEU, YRI, CHB, JPT, Hap-
map release #3) were employed through a principal component 
analysis within Eigenstrat (Price et al., 2006) to identify individu-
als with divergent ancestry. Sixteen individuals (6 twin pairs and 
4 SCT cases) were identified as having African ancestry and 21 
individuals (6 twin pairs and nine SCT family members) were 
identified as having Asian ancestry. Any SNPs that showed a sig-
nificant association with non-European ancestry (P < 0.0001) 
were excluded. The final genome-wide dataset consisted 
Table 1. Assessment battery.
Instrument Measure
Woodcock Johnson III Tests of Cognitive Abilities 
(Woodcock et al., 2007)
Verbal Comprehension
NEPSY: A Developmental Neuropsychological Assessment 
(Korkman et al., 1998)
Repetition of Nonsense Words
Oromotor Sequences
Sentence Repetition






The Children’s Communication Checklist-2 (CCC-2) (Bishop, 2003)
The Social Responsiveness Scale (SRS) (Constantino, 2005)
For the NEPSY tests, norms extend only to age 12 yr 11 months, and so we used extrapolated scores, as 
documented in Appendix 1.
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of 500 individuals (130 independent SCT cases and 370 twins, 
divided into two subgroups) and 451093 autosomal SNPs with 
a genotyping rate of 99.78%.
Procedure
Ethical approval was obtained for the study in 2011 from 
the Berkshire NHS Research Ethics Committee (reference 11/
SC/0096), and data collection started in August of that year, 
finishing in October 2016. Information sheets, consent forms 
and ethics approval documents are available on Open Science 
Framework. Families who had expressed interest in the study were 
interviewed by telephone to assess whether the child met inclu-
sion criteria, and if so, an appointment was made to see the child 
at home or at school, depending on parental preference. Fami-
lies were widely dispersed around the UK, including Northern 
Ireland, Scotland, Wales and England. During the course of recruit-
ment a total of eight research assistants as well as the senior 
author were involved in assessing children. The assessment 
was conducted in a single session lasting between 2–3 hours 
per child, with breaks where needed.
Analysis plan
Study data are analysed using R software (R Core Team, 2016), 
with the main database managed using REDCap electronic data 
capture tools hosted at the University of Oxford (Harris et al., 
2009).
Potentially, there is a very large number of genotypes 
and phenotypes that could be analysed to test our hypothesis, 
as well as different ways of creating subgroups. This consid-
eration, coupled with the small sample size, makes it important 
to control adequately for multiple testing to guard against type I 
error (Grabitz et al., 2018). For this reason, we stored pheno-
type and genotype data separately and specified an analysis plan 
in detail, as reported here. The analysis of genotype-phenotype 
associations will be conducted after this plan is registered and 
peer-reviewed.
Subgroups
In our main pre-specified analysis we will treat all three 
trisomies together. This is because, the two hypotheses that 
we are considering assume a common mechanism that would 
apply regardless of karyotype. If we find an association between 
genotype and phenotype, we will carry out exploratory analyses 
to consider whether this is moderated by karyotype.
Prioritising genotypes for analysis
We conducted a series of literature searches to prioritise 
autosomal genes for analysis, focusing on genes that had an 
association with childhood speech and language disorders and 
that were relevant for synaptic function (see Appendix 4). This 
led us to select two candidates; CNTNAP2 and NRXN1. Both 
of these genes are large (>1 MB) and included over 100 SNPs 
from the genotyping array. In order to avoid false positives with 
our small sample size, we chose to focus our analysis on regions 
that have previously been associated with neurodevelopmental 
disorder, analysing all genotyped SNPs (after quality control 
steps described above (see “DNA collection and analysis”) within 
these selected regions.
In CNTNAP2 (NM_014141), we focused on a region 
spanning exons 13-14 (chr7:147,514,390-147,612,852 (hg19)). 
We had direct genotype data for 22 SNPs across this region. 
In addition, we used imputation to obtain genotypes for SNPs 
rs2710102 and rs7794745. These were the first SNPs reported to 
be associated with ASD, and represent the main two SNPs used 
in the majority of association studies in neurodevelopmental 
disorders (Alarcón et al., 2008; Arking et al., 2008). These two 
SNPs were not directly genotyped on the Illumina arrays and 
were therefore imputed for all individuals. Imputation was per-
formed on the Michigan Imputation Server, an online server 
which generates phased and imputed genotypes using 
high-density reference panels. Variant Call Files (VCF) were 
uploaded for 15936 SNPs genotyped on chromosome 7. Geno-
types were phased within Eagle and imputed by Minimac against 
the Human Reference Panel hrc.r1.1.2016, which includes 
64,940 haplotypes of predominantly European ancestry. In total, 
genotypes were generated for 2,289,829 SNPs across chromo-
some 7,513,970 of which had quality scores 0.9. The two SNPs 
of interest, rs2710102 and rs7794745 had quality scores 
of 0.9938 and 0.94127 respectively.
The second candidate is NRXN1 (NM_004801). Although this 
gene met our criteria of being relevant for both synaptic func-
tion and neurodevelopmental phenotypes, the studies showing 
this link involved deletions rather than common variants (Ching 
et al., 2010). A recent analysis of clinical microarray data 
showed that deletions in exons near the 5ʹ end of NRXN1 were 
specifically implicated in neurodevelopmental disorders (Lowther 
et al., 2017). Accordingly, we focused on 23 SNPs in this region 
of the gene chr2:51,141,501-51,280,121 (hg19)). These SNPs 
covered exons 1–4 plus 20Kb upstream (5’) of the gene as this 
region includes important regulatory sequences. Details of the 
SNPs included in the analysis are shown with Appendix material.
Statistical methods
CNTNAP2 and NRXN1 genes from the trisomy sample 
will be analysed for association with a latent variable based on 
the three phenotypes using a structural equation modelling (SEM) 
approach adapted for genetic analysis (Romdhani et al., 2015). 
The model specification for our analysis is shown in Figure 4.
Romdhani et al. (2015) use the Generalized Structured Com-
ponent Analysis (GSCA) developed by Hwang & Takane 
(2004). This method uses partial least squares path modelling 
rather than traditional covariance-based SEM, allowing adequate 
model fit to be achieved when using smaller samples (Chin & 
Newstead, 1999; Tenenhaus et al., 2005). The measurement mod-
els in the SEM framework are not typical regression format using 
latent factors; instead they are fitted applying a weighted sum 
approach, which is similar to principal components analysis. 
The advantage of this approach is that it does not attempt to fit 
the whole covariance matrix for observed and latent variables, but 
rather fits a separate measurement model for the contribution of 
observed variables to each latent factor, and then fits a covariance 
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model for the latent factors. Hence, we do not estimate the 
contribution of individual SNPs in each gene to the pheno-
type; rather, their influence is represented via the weighted 
sum. Similarly, the latent phenotypic factor (termed Neuro in 
Figure 4) is a weighted sum of the three measures of the 
phenotype. We will estimate the significance of one direct 
pathway from the CNTNAP2 gene to the latent phenotype, and 
one from NRXN1 to the latent phenotype. This method thus 
gives a single estimate of the overall impact of SNPs in a region 
on the phenotype.
We conducted simulations that indicated that this method 
is feasible with the number of SNPs and phenotypes in our sam-
ple (see Appendix 5): the permutation method, used by this 
approach to effectively quantify the test statistic distribution, 
generates p-values independently for each path, and a correc-
tion is required to take this into account. Because the evidence 
of association of common variants was stronger for CNTNAP2 
than for NRXN1, we used a sequential approach to setting 
a significance level (alpha), using a critical p-value of .05 to 
test the pathway from CNTNAP2 to the Neuro factor, and .025 for 
the pathway from NRXN1 to the Neuro factor.
In addition, we will do the same analyses with children from 
the two comparison samples.
We predict that one or both paths from CNTNAP2 and NRXN1 
to the Neurodev factor will indicate significant association in 
the sex chromosome trisomy sample. We further predict that 
any associations in the comparison samples will be similar in 
direction, but smaller in size in the comparison sample, and may 
not reach statistical significance.
Any additional analyses of subgroups or phenotypes suggested 
by inspecting the data will be treated as exploratory and in 
need of replication in another sample.
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